Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,186 | -6,170 | -8,374 | -17,549 | -13,343 |
| Depreciation Amortization | 119 | 186 | 184 | 118 | 119 |
| Accounts receivable | -378 | 356 | 563 | 2,028 | -3,230 |
| Other Working Capital | -986 | 571 | 308 | 2,891 | -3,636 |
| Other Operating Activity | 1,108 | 166 | 684 | 233 | 6,426 |
| Operating Cash Flow | $-7,322 | $-4,890 | $-6,637 | $-12,279 | $-13,665 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -6 | -6 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-6 | $-6 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -30 | N/A | N/A | N/A |
| Common Stock Issued | 7,718 | 729 | 5,116 | 11,958 | 1,512 |
| Common Stock Repurchased | -329 | -108 | -285 | -328 | 12,662 |
| Other Financing Activity | 9,642 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $17,031 | $592 | $4,830 | $11,630 | $14,175 |
| Exchange Rate Effect | 46 | -26 | 77 | -93 | 122 |
| Beginning Cash Position | 1,037 | 5,361 | 7,091 | 7,839 | 7,214 |
| End Cash Position | 10,792 | 1,037 | 5,361 | 7,091 | 7,839 |
| Net Cash Flow | $9,755 | $-4,324 | $-1,730 | $-748 | $626 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,322 | -4,890 | -6,637 | -12,279 | -13,665 |
| Capital Expenditure | N/A | N/A | N/A | -6 | -6 |
| Free Cash Flow | -7,322 | -4,890 | -6,637 | -12,285 | -13,671 |